Lightning Round: Sarepta Therapeutics, Splunk, Sony and More
Franco-Nevada : Jim Cramer called this stock a "winner."
Sarepta Therapeutics : Cramer likes this stock right now, but only on a speculative basis.
Splunk : The "Mad Money" host can't recommend this stock right now.
Boardwalk Pipeline Partners : This is one of Cramer's favorite master limited partnerships in the pipeline space.
Under Armour : While this company is doing good, Cramer noted it's chart is doing bad.
Sony : This is one bad stock that lacks a catalyst to push higher, Cramer said.
@MadMoneyOnCNBC on Twitter
"Mad Money" on Facebook
Call Cramer: 1-800-743-CNBC
Questions for Cramer? email@example.com
Questions, comments, suggestions for the "Mad Money" website? firstname.lastname@example.org